Literature DB >> 8960119

Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching.

A N Goldfarb1, J P Flores, K Lewandowska.   

Abstract

The basic helix-loop-helix (bHLH) transcriptional factor E2A has previously been shown to play a critical role in early B cell development, with E2A knockout mice and Id1 transgenic mice showing an arrest at the pro-B cell stage of development. More recent data suggest that E2A, through an interaction with the immunoglobulin heavy chain 3' enhancer, might also regulate later events in B cell development such as heavy chain class switching. The patterns of E2A protein expression in secondary lymphoid tissues support a role in later stages of B cell maturation. In particular, immunostaining reveals upregulation of E2A protein in cells of the dark zone of the germinal center, the site of immunoglobulin heavy chain class switching. To examine the role of E2A in class switching, the inhibitory HLH protein Id1 was expressed in B cell lines which normally undergo spontaneous and inducible switching from IgM to IgA. The forced expression of Id1 in these cell lines effectively blocked class switching. This Id1 blockade of class switching did not occur via downregulation of immunoglobulin heavy chain germline transcription or through inhibition of cell cycling. Furthermore, Id1 inhibited spontaneous and, to a lesser degree, cytokine inducible class switching. From these data, we conclude that E2A plays an important role in the class switching process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960119     DOI: 10.1016/s0161-5890(96)00047-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.

Authors:  M E Massari; R R Rivera; J R Voland; M W Quong; T M Breit; J J van Dongen; O de Smit; C Murre
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Restricted expression of E2A protein in primary human tissues correlates with proliferation and differentiation.

Authors:  M N Rutherford; D P LeBrun
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

5.  Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.

Authors:  Elena Cubedo; Andrew J Gentles; Chuanxin Huang; Yasodha Natkunam; Shruti Bhatt; Xiaoqing Lu; Xiaoyu Jiang; Isabel Romero-Camarero; Aharon Freud; Shuchun Zhao; Carlos E Bacchi; Jose A Martínez-Climent; Isidro Sánchez-García; Ari Melnick; Izidore S Lossos
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

Review 6.  AID and somatic hypermutation.

Authors:  Robert W Maul; Patricia J Gearhart
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 7.  Helix-Loop-Helix Proteins in Adaptive Immune Development.

Authors:  Megan Aubrey; Zachary J Warburg; Cornelis Murre
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

8.  Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Authors:  Sujatha Nagulapalli; Aisha Goheer; Leslie Pitt; Lawrence P McIntosh; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 9.  E proteins in lymphocyte development and lymphoid diseases.

Authors:  Ian Belle; Yuan Zhuang
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

10.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.